BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 36050817)

  • 1. Monitoring for atrial fibrillation prior to patent foramen ovale closure after cryptogenic stroke.
    Diener HC; Wachter R; Wong A; Thijs V; Schnabel RB; Ntaios G; Kasner S; Rothwell PM; Passman R; Saver JL; Albers BA; Bernstein RA
    Int J Stroke; 2023 Apr; 18(4):400-407. PubMed ID: 36050817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Embolic Stroke of Undetermined Source and Patent Foramen Ovale: Risk of Paradoxical Embolism Score Validation and Atrial Fibrillation Prediction.
    Strambo D; Sirimarco G; Nannoni S; Perlepe K; Ntaios G; Vemmos K; Michel P
    Stroke; 2021 May; 52(5):1643-1652. PubMed ID: 33784832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patent foramen ovale closure in the management of cryptogenic stroke: a review of current literature and guideline statements.
    Elzanaty AM; Patel N; Sabbagh E; Eltahawy EA
    Curr Med Res Opin; 2021 Mar; 37(3):377-384. PubMed ID: 33460329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. From cryptogenic to ESUS: Toward precision medicine?
    Timsit S
    Rev Neurol (Paris); 2022 Nov; 178(9):939-952. PubMed ID: 35597610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of recurrent events in patients with cryptogenic stroke and patent foramen ovale within the CLOSURE I (Evaluation of the STARFlex Septal Closure System in Patients With a Stroke and/or Transient Ischemic Attack Due to Presumed Paradoxical Embolism Through a Patent Foramen Ovale) trial.
    Elmariah S; Furlan AJ; Reisman M; Burke D; Vardi M; Wimmer NJ; Ling S; Chen X; Kent DM; Massaro J; Mauri L;
    JACC Cardiovasc Interv; 2014 Aug; 7(8):913-20. PubMed ID: 25147037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcranial Doppler Screening for Patent Foramen Ovale Closure in Cryptogenic Strokes in Young: A Single Center Experience from South India.
    Bal D; Ahmed Shaikh AI; Rayani M; Aaron S; Thompson VS; Jose J; Krupa J; Benjamin RN; Rajkumar JL; Prabhakar AT
    J Assoc Physicians India; 2022 Oct; 70(10):11-12. PubMed ID: 37355867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term risk of atrial fibrillation or flutter after transcatheter patent foramen ovale closure: a nationwide Danish study.
    Skibsted CV; Korsholm K; Pedersen L; Bonnesen K; Nielsen-Kudsk JE; Schmidt M
    Eur Heart J; 2023 Sep; 44(36):3469-3477. PubMed ID: 37279491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of atrial fibrillation after transcatheter closure of patent foramen ovale in patients with or without cryptogenic stroke.
    Bronzetti G; D'Angelo C; Donti A; Salomone L; Giardini A; Maria Picchio F; Boriani G
    Int J Cardiol; 2011 Jan; 146(1):17-21. PubMed ID: 19487038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of atrial fibrillation in cryptogenic stroke with patent foramen ovale closure: protocol for the prospective, observational PFO-AF study.
    Badoz M; Derimay F; Serzian G; Besutti M; Rioufol G; Frey P; Guenancia C; Ecarnot F; Meneveau N; Chopard R
    BMJ Open; 2023 Sep; 13(9):e074584. PubMed ID: 37699623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac and Echocardiographic Markers in Cryptogenic Stroke with Incidental Patent Foramen Ovale.
    Tateishi Y; Ueno Y; Tsujino A; Kuriki A; Kamiya Y; Shimizu T; Doijiri R; Yamaguchi E; Kikuno M; Shimada Y; Takekawa H; Koga M; Ihara M; Hirata K; Hasegawa Y; Toyoda K; Hattori N; Urabe T;
    J Stroke Cerebrovasc Dis; 2021 Aug; 30(8):105892. PubMed ID: 34107415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Propensity-score matched analysis of patent foramen ovale closure in real-world study cohort with cryptogenic ischemic stroke.
    Low CE; Teo YN; Teo YH; Lim ICZ; Rana S; Lee YQ; Chen X; Fang JT; Lam HH; Ong K; Yang J; Kuntjoro I; Low TT; Lee EC; Sharma VK; Yeo LL; Sia CH; Tan BY; Lim Y
    J Stroke Cerebrovasc Dis; 2023 Dec; 32(12):107407. PubMed ID: 37804781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ignored Role of Paroxysmal Atrial Fibrillation in the Pathophysiology of Cryptogenic Stroke in Patients with Patent Foramen Ovale and Atrial Septal Aneurysm.
    Yetkin E; Atmaca H; Çuğlan B; Yalta K
    Curr Cardiol Rev; 2024; 20(2):14-19. PubMed ID: 38367262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New-onset atrial fibrillation following percutaneous closure of patent foramen ovale: a systematic review and meta-analysis.
    Oliva L; Huszti E; Barker M; Frankfurter C; Hall R; Horlick E; Abrahamyan L
    J Interv Card Electrophysiol; 2021 Mar; 60(2):165-174. PubMed ID: 33420712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insertable cardiac monitor detection of silent atrial fibrillation in candidates for percutaneous patent foramen ovale closure.
    Scacciatella P; Jorfida M; Biava LM; Meynet I; Zema D; D'Ascenzo F; Pristipino C; Cerrato P; Giustetto C; Gaita F
    J Cardiovasc Med (Hagerstown); 2019 May; 20(5):290-296. PubMed ID: 30921267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of Paradoxical Embolism (RoPE)-Estimated Attributable Fraction Correlates With the Benefit of Patent Foramen Ovale Closure: An Analysis of 3 Trials.
    Kent DM; Saver JL; Ruthazer R; Furlan AJ; Reisman M; Carroll JD; Smalling RW; Jüni P; Mattle HP; Meier B; Thaler DE
    Stroke; 2020 Oct; 51(10):3119-3123. PubMed ID: 32921262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Closure of patent foramen ovale or medical therapy alone for secondary prevention of cryptogenic cerebrovascular events.
    Fortuni F; Crimi G; Leonardi S; Angelini F; Raisaro A; Lanzarini LF; Oltrona Visconti L; Ferrario M; De Ferrari GM
    J Cardiovasc Med (Hagerstown); 2018 Jul; 19(7):373-381. PubMed ID: 29708911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Net clinical benefit of patent foramen ovale closure in patients with cryptogenic stroke: Meta-analysis and meta-regression of randomized trials.
    Pasceri V; Pelliccia F; Bressi E; Mantione L; Gaudio C; Speciale G; Mehran R; Dangas GD; Patti G
    Int J Cardiol; 2018 Sep; 266():75-80. PubMed ID: 29887476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical vs. drug therapy in patients with patent foramen ovale and cryptogenic stroke.
    Liu Y; Wu Y; Xiong L
    Herz; 2021 Jun; 46(3):250-254. PubMed ID: 32394019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New-onset atrial fibrillation after percutaneous patent foramen ovale closure: a meta-analysis.
    Jurczyk D; Macherey-Meyer S; Rawish E; Stiermaier T; Eitel I; Frerker C; Schmidt T
    Clin Res Cardiol; 2023 Dec; 112(12):1824-1834. PubMed ID: 37515604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of atrial septal defect and patent foramen ovale in cryptogenic strokes.
    Delabays C; Correia P; Eeckhout E; Delabays A; Michel P
    J Stroke Cerebrovasc Dis; 2024 Jun; 33(6):107664. PubMed ID: 38428550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.